KINTAI THERAPEUTICS Trademark

Trademark Overview


On Wednesday, January 17, 2018, a trademark application was filed for KINTAI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KINTAI THERAPEUTICS trademark a serial number of 87758793. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 5, 2021. This trademark is owned by VL45, Inc.. The KINTAI THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nep...
kintai therapeutics

General Information


Serial Number87758793
Word MarkKINTAI THERAPEUTICS
Filing DateWednesday, January 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSENDA BIOSCIENCES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Party NameKINTAI THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameKINTAI THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameVL45, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, April 5, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 9, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, August 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2020EXTENSION 3 GRANTED
Thursday, August 27, 2020EXTENSION 3 FILED
Thursday, August 27, 2020TEAS EXTENSION RECEIVED
Monday, July 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 9, 2020EXTENSION 2 GRANTED
Friday, February 28, 2020EXTENSION 2 FILED
Monday, March 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 28, 2020TEAS EXTENSION RECEIVED
Saturday, September 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 5, 2019EXTENSION 1 GRANTED
Thursday, September 5, 2019EXTENSION 1 FILED
Thursday, September 5, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 27, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, November 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 27, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, November 27, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 3, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, May 3, 2018PRIORITY ACTION E-MAILED
Thursday, May 3, 2018PRIORITY ACTION WRITTEN
Friday, April 27, 2018ASSIGNED TO EXAMINER
Wednesday, March 14, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM